Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

Small-molecule technology could soon make easy-to-take GLP-1 pills a reality. ... (16 pounds on average, or about 7.9 percent body weight) that are competitive with injectable GLP-1s like Ozempic.

A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...